US 10406222
Human antibodies to Middle East Respiratory Syndrome—coronavirus spike protein
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 10406222 (Human antibodies to Middle East Respiratory Syndrome—coronavirus spike protein) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K38/00, A61K39/12